Latanoprost–netarsudil (Roclanda, Santen) is indicated 'for the reduction of elevated intraocular pressure (IOP) in adult patients with primary open-angle glaucoma or ocular hypertension for whom monotherapy with a prostaglandin or netarsudil provides insufficient IOP reduction'.
The dosage schedule is available in the summary of product characteristics for latanoprost–netarsudil.
The list price for latanoprost–netarsudil is £10.00 per 2.5‑ml bottle (excluding VAT; company submission, April 2024, subject to approval).
Costs may vary in different settings because of negotiated procurement discounts.